Struthers Richard Scott bought CRNX
August 7, 2026 · Form 4 insider transaction
Struthers Richard Scott bought 3,969 shares of Crinetics Pharmaceuticals, Inc. at $25.19 per share, a transaction worth $100.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,969
Price
$25.19
Total value
$100.0K
InsiderStruthers Richard Scott
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 7, 2026
Filing dateAugust 11, 2026
Shares owned after408,747
OwnershipDirect
10b5-1 planNo
AmendedNo